Abstract—In order to investigate the joint influence of C1473G polymorphism in the gene encoding the key enzyme for serotonin (5-HT) biosynthesis in brain – tryptophan hydroxylase-2, and the distal fragment (103,9-112,4 Мbp) of chromosome 13, including 5-HT1A serotonin receptor gene from catalepsy-prone CBA strain, on the brain 5-HT system, new recombinant mice strain B6-1473GG.CBA-CD13Mit76С (1473GG-76C) and B6-1473GG.CBA-D13Mit76В (1473GG-76B) on the base of C57BL/6 strain were created. The 1473GG-76C and 1473GG-76B lines carry a fragment of chromosome 13 containing Htr1a gene from the CBA and the C57BL/6 strains respectively. Both lines are homozygous by 1473G-allele, reducing the activity of TPH-2. It was shown that the 1473GG-76C line is characterized by increased levels of mRNA of Htr1a, Htr2a genes and Maoa gene (monoamine oxidase type A—the main enzyme of 5-HT degradation) in the midbrain, Htr1a gene in the cortex, Htr1a and Htr2a genes in the hippocampus as compared to 1473GG-76B. In addition, the 1473GG-76C line has increased expression of genes encoding the key regulators of Htr1a gene—FREUD-1 and FREUD-2. The mRNA level of the Cc2d1a gene encoding FREUD-1 was increased in the cortex, and the expression of the Cc2d1b gene encoding FREUD-2 was enhanced in the midbrain. Also, the 1473GG-76C line has increased 5-HT levels in the midbrain, hypothalamus and hippocampus. At the same time, the level of the main 5-HT metabolite, 5-HIAA, was decreased in the midbrain and cortex of these mice. The ratio of 5-HIAA/5-HT reflecting the intensity of 5-HT metabolism was reduced in all investigated structures of 1473GG-76C mice. Thus, the combination of 1473G-allelele of Tph2 gene with Htr1a gene from the CBA strain had a significant effect on the mRNA levels of the key genes of the 5-HT system and on 5-HT metabolism in the brain of 1473GG-76C mice.
Similar content being viewed by others
REFERENCES
Murphy, D.L., Andrews, A.M., Wichems, C.H., Li, Q., Tohda, M., and Greenberg, B., The J. Clin. Psychiatry, 1998, vol. 59, Suppl. 15, pp. 4–12.
Fitzpatrick, P.F., Annual Review Biochem., 1999, vol. 68, pp. 355–381.
Osipova, D.V., Kulikov, A.V., Mekada, K., Yoshiki, A., Moshkin, M.P., Kotenkova, E.V., and Popova, N.K., Genes, Brain, and Behavior, 2010, vol. 9, no. 5, pp. 537–543.
Kulikov, A.V., Osipova, D.V., Naumenko, V.S., and Popova, N.K., Genes, Brain, and Behavior, 2005, vol. 4, no. 8, pp. 482–485.
Kulikov, A.V., Osipova, D.V., Naumenko, V.S., and Popova, N.K., Dokl. Akad. Nauk, 2005, vol. 402, no. 4, pp. 571–573.
Bazhenova, E.Y., Sinyakova, N.A., Kulikova, E.A., Kazarinova, I.A., Bazovkina, D.V., Gainetdinov, R.R., and Kulikov, A.V., Neurosci. Lett., 2017, vol. 653, pp. 264–268.
Bazhenova, E.Y., Bazovkina, D.V., Kulikova, E.A., Fursenko, D.V., Khotskin, N.V., Lichman, D.V., and Kulikov, A.V., Neurosci. Lett., 2017, vol. 640, pp. 105–110.
Bazhenova, E.Y., Fursenko, D.V., Kulikova, E.A., Khotskin, N.V., Sinyakova, N.A., and Kulikov, A.A., Neurosci. Lett., 2019, vol. 699, pp. 91–96.
Pytliak, M., Vargova, V., Mechirova, V., and Felsoci, M., Physiol. Res., vol. 60, no. 1, pp. 15–25.
Naumenko, V.S., Popova, N.K., Lacivita, E., Leopoldo, M., and Ponimaskin, E.G., CNS Neurosci. Ther., 2014, vol. 20, no. 7, pp. 582–590.
Popova, N.K. and Naumenko, V.S., Reviews Neurosci., 2013, vol. 24, no. 2, pp. 191–204.
Barnes, N.M. and Sharp, T., Neuropharmacology, 1999, vol. 38, no. 8, pp. 1083–1152.
Zifa, E. and Fillion, G., Pharmacological Rev., 1992, vol. 44, no. 3, pp. 401–458.
Ou, X.M., Jafar-Nejad, H., Storring, J.M., Meng, J.H., Lemonde, S., and Albert, P.R., J. Biol. Chem., 2000, vol. 275, no. 11, pp. 8161–8168.
Ou, X.M., Lemonde, S., Jafar-Nejad, H., Bown, C.D., Goto, A., Rogaeva, A., and Albert, P.R., J. Neurosci., 2003, vol. 23, no. 19, pp. 7415–7425.
Hadjighassem, M.R., Austin, M.C., Szewczyk, B., Daigle, M., Stockmeier, C.A., and Albert, P.R., Biol Psychiatry, 2009, vol. 66, no. 3, pp. 214–222.
Hadjighassem, M.R., Galaraga, K., and Albert, P.R., Eur. J. Neurosci., 2011, vol. 33, no. 2, pp. 214–223.
Rogaeva, A. and Albert, P.R., Eur. J. Neurosci, 2007, vol. 26, no. 4, pp. 965–974.
Rogaeva, A., Galaraga, K., and Albert, P.R., J. Neurosci. Res., 2007, vol. 85, no. 13, pp. 2833–2838.
Albert, P.R., Le Francois, B., and Millar, A.M, Molecular Brain, 2011, vol. 4, pp.21.
Kulikova, E.A., Bazovkina, D.V., Akulov, A.E., Tsybko, A.S., Fursenko, D.V., Kulikov, A.V., Naumenko, V.S., Ponimaskin, E., and Kondaurova, E.M., British J. Pharmacology, 2016, vol. 173, no. 13, pp. 2147–2161.
Kulikova, E.A., Bazovkina, D.V., Antonov, Y.V., Akulov, A.E., Kulikov, A.V., and Kondaurova, E.M., Neurosci. Res., 2017, vol. 117.
Osipova, D.V., Kulikov, A.V., and Popova, N.K., J. Neurosci Res., 2009, vol. 87, no. 5, pp. 1168–1174.
Zhang, X., Beaulieu, J.M., Sotnikova, T.D., Gainetdinov, R.R., and Caron, M.G., Science (Washington, D.C.), 2004, vol. 305, no. 5681, p. 217.
Kulikov, A.V., Bazovkina, D.V., Mauzan, M.P., and Mormed, P., Doklady Akademii Nauk, 2003, vol. 393, no. 1, pp. 134–137.
Kulikov, A.V., Naumenko, V.S., Voronova, I.P., Tikhonova, M.A., and Popova, N.K., J. Neurosci Methods, 2005, vol. 141, no. 1, pp. 97–101.
Naumenko, V.S. and Kulikov, A.V., Molekuliarnaia Biologiia, 2006, vol. 40, no. 1, pp. 37–44.
Naumenko, V.S., Osipova, D.V., Kostina, E.V., and Kulikov, A.V., J. Neurosci. Methods, 2008, vol. 170, no. 2, pp. 197–203.
Moisan, M.-P., in Neurobehavioral Genetics. Methods and Applications, Jones, B.C. and Mormede, P, Eds., Boca Raton, FL: CRC Press, 1999, pp. 71–91.
Hicks, P.B., Life Sci., 1990, vol. 47, no. 18, pp. 1609–1615.
Wadenberg, M.L., Neurosci. Biobehav. Rev., 1996, vol. 20, no. 2, pp. 325–339.
Egashira, N., Koushi, E., Mishima, K., Iwasaki, K., Oishi, R., and Fujiwara, M., J. Pharmacological Sciences, 2007, vol. 105, no. 4, pp. 361–366.
Hensler, J.G. and Truett, K.A., Neuropsychopharmacology, 1998, vol. 19, no. 5, pp. 354–364.
Valdez, M., Burke, T.F., and Hensler, J.G., Brain Res., 2002, vol. 957, no. 1, pp. 174–182.
Zhang, Y., D’Souza, D., Raap, D.K., Garcia, F., Battaglia, G., Muma, N.A., and Van de Kar, L.D., J. Neurosci., 2001, vol. 21, no. 20, pp. 7919–7927.
Zhang, Y., Gray, T.S., D’Souza, D.N., Carrasco, G.A., Damjanoska, K.J., Dudas, B., Garcia, F., Zainelli, G.M., Sullivan, HanleyN.R., Battaglia, G., Muma, N.A., and Van de Kar, L.D., J. Pharmacol. Exp. Ther., 2004, vol. 310, no. 1, pp. 59–66.
Popova, N.K., Ponimaskin, E.G., and Naumenko, V.S., Ross. Fiziol. Zhurn. im. I.M. Sechenova, 2015, vol. 101, no. 11, pp. 1270–1278.
Naumenko, V.S., Bazovkina, D.V., Kondaurova, E.M., Zubkov, E.A., and Kulikov, A.V., Genes, Brain, and Behavior, 2010, vol. 9, no. 5, pp. 519–524.
Borroto-Escuela, D.O., Narvaez, M., Ambrogini, P., Ferraro, L., Brito, I., Romero-Fernandez, W., Andrade-Talavera, Y., Flores-Burgess, A., Millon, C., Gago, B., Narvaez, J.A., Odagaki, Y., Palkovits, M., Diaz-Cabiale, Z., and Fuxe, K., Molecules, 2018, vol. 23, no. 6, p. 1341.
Kulikov, A.V., Bazovkina, D.V., Kondaurova, E.M., and Popova, N.K., Genes, Brain, and Behavior, 2008, vol. 7, no. 4, pp. 506–512.
Kulikov, A.V., Bazovkina, D.V., Moisan, M.P., and Mormede, P., Dokl. Biol. Sci, 2003, vol. 393, pp. 531–534.
Kondaurova, E.M., Bazovkina, D.V., Kulikov, A.V., and Popova, N.K., Genes, Brain, and Behavior, 2006, vol. 5, no. 8, pp. 596–601.
Naumenko, V.S., Kondaurova, E.M., Kulikov, A.V., and Popova, N.K., Dokl. Akad. Nauk, 2006, vol. 409, no. 1, pp. 133–135.
Funding
This study was supported by the Russian Science Foundation (grant no. 19-15-00027). The maintenance of the animals was supported by the basic research project no. 0259-2019-0002-С-01.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest. The authors declare that they have no conflict of interest.
Statement on the welfare of animals. The experimental animals were bred and managed, and all procedures were performed in accordance with the International Guide for the Care and Use of Laboratory Animals, Eighth Edition, Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council © 2011 National Academy of Sciences (United States) and national documents: Guidelines for Good Laboratory Practice in the Russian Federation adopted by the order of Ministry of Health of the Russian Federation No. 199n of April 01, 2016; GOST standards 33215-2014 “Guidelines for the Breeding, Care and Management of Laboratory Animals” (Guidelines on Laboratory Animal Facilities and Animal Procedures, adopted July 1, 2015). The conditions for breeding of animals and the experimental procedures were approved by the ethics committee of the Institute of Cytology and Genetics (Novosibirsk, Russia).
Rights and permissions
About this article
Cite this article
Rodnyy, A.Y., Belokopytova, I.I., Antonov, E.V. et al. Investigation of the Brain Serotonin System Plasticity Using the Recombinant Mouse Lines Carring 1473G–Allele of Tryptophan Hydroxylase-2 Gene and Differing by the Distal Fragment of Chromosome 13 Containing 5-HT1A Receptor Gene. Neurochem. J. 14, 384–393 (2020). https://doi.org/10.1134/S1819712420040078
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1819712420040078